Transporting Covid-19 vaccine: We can keep it cold with helium says SA producer

It turns out helium is not only good for voice tricks with party balloons – it could also be a useful tool in the fight against Covid-19.

The coronavirus vaccine requires temperature-controlled packaging during transportation.

Helium and domestic natural gas producer Renergen has come up with a solution to this logistical problem.

It’s patenting the “Cryo-Vacc”, stacked aluminium boxes that can transport the vaccine safely for a period of 30 days.

Bruce Whitfield interviews Renergen CEO Stefano Marani about this new use for helium.

[In the Free State] it’s the highest concentration in the world… thanks to an asteroid! The gas is underground; we drill… and we separate it from the methane, making both LNG and liquid helium which then gets used in various industrial applications.
Stefano Marani, CEO – Renergen

The vaccine is -70° and dry ice is only marginally below that… Helium is -269° Celsius, or just three above absolute zero… We turn it into a liquid.
Stefano Marani, CEO – Renergen

In liquid form helium is cheaper to transport. We use the fact that it’s in liquid form to move it all over the world.
Stefano Marani, CEO – Renergen

Moving something like a Covid-19 vaccine around at -70° is tricky because time is against you, Marani says.

What they’re utilising is helium’s ability to store cold energy.

We designed and applied for a patent for this little aluminium case that you could use to transport a minimum of 100 doses.
Stefano Marani, CEO – Renergen

The liquid helium boils as it should because it’s warming up and creates vapour which we use to circulate throughout the box and keep the vaccine at -70° for up to 30 days.
Stefano Marani, CEO – Renergen

We’d only be able to use anything from our plant when it comes online which is third quarter next year.
Stefano Marani, CEO – Renergen

Facebook
Twitter
LinkedIn
WhatsApp
Email

Fill out this form and one of our experts will be in touch to discuss how we can help you.

    Sign up to our news